Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Clinical trial NCT06603987 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06603987
Sponsor: Stella Pharma Corporation
Status: ENROLLING_BY_INVITATION
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Thoracic Solid Malignant Tumor

Start date: 2025-04-10
Primary completion: 2028-10-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.